From: The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis
Study (year) | Study type | No. IA vs IV | Age: IA vs IV | TXA group | Transfusion criteria | Thromboprophylaxis | Level of evidence |
---|---|---|---|---|---|---|---|
Alshryda 2013 [22] | RCT | 80/81 | 66/63 | 1 g | Hb <70 g/l | LMWH | A |
BagsBy 2014 [24] | nRCT | 91/90 | 61.4/61.9 | 1 g | Hb <70 g/l | Warfarin/Asprin | B |
Chang 2014 [14] | nRCT | 154/234 | 57.2/56.7 | 3 g | Hb <100 g/l | -- | B |
Ding 2014 [23] | nRCT | 30/30 | 60/61 | 3 g | Hb <80 g/l | -- | B |
Fan 2014 [15] | RCT | 55/44 | 66.0/66.5 | 2 g | Hb <70 g/l | Physical | A |
Gilbody 2014 [16] | nRCT | 86/88 | 64/65 | 3 g | Hb <80 g/l | enoxaparin | B |
Konig G 2013 [17] | nRCT | 91/40 | 60/59 | 3 g | Hb <80 g/l | -- | B |
Machin 2014 [26] | nRCT | 50/100 | 61/67.5 | 0.5 g | Hb <80 g/l | dabigatran | B |
Martin JG 2014 [25] | RCT | 25/25 | 63.9/63.0 | 2 g | Hb <70 g/l | Physical | A |
Van Elst CE 2013 [18] | RCT | 30/30 | 67.1/66.5 | 3 g | Hb <100 g/l | LMWH | A |
Wei 2014 [19] | RCT | 102/100 | 60.2/63.9 | 3 g | Hb <90 g/l | LMWH | A |
Wind 2014 [27] | nRCT | 70/1047 | 65/60 | -- | Hb <80 g/l | -- | C |
Yin 2014 [20] | RCT | 30/30 | 50/53 | 2 g | Hb < 70 g/l | LMWH | A |
Yue C 2014 [21] | RCT | 52/49 | 60.9/63.7 | 3 g | Hb <70 g/l | LWMH | A |